Focalin and Focalin XR (dexmethylphenidate) for adults

Focalin is the brand name for dexmethylphenidate, a refined form of methylphenidate. It comes as immediate-release tablets (Focalin) and extended-release capsules (Focalin XR). The two labels say different things about adults, and only one of them describes adult studies. This page summarizes both current FDA labels on DailyMed (checked October 19, 2026). It gives no doses and does not tell anyone to start, stop or change a medication.

What dexmethylphenidate is

Ordinary methylphenidate, the ingredient in Ritalin and Concerta, is a mix of two mirror-image forms. The Focalin labels describe dexmethylphenidate as the "d-threo enantiomer of racemic methylphenidate," meaning it contains only one of those two forms. It is a central nervous system (CNS) stimulant, and the labels say its mode of action in ADHD "is not known." It is a Schedule II controlled substance. Because it is a different ingredient from regular methylphenidate, the two are not swapped one-for-one; the labels give separate instructions for people switching from methylphenidate.

Adult approval at a glance

So, does the label cover adults? For Focalin XR, yes: the indication is not limited by age, and the label includes an adult trial and adult dosing. For the immediate-release tablet, the indication is also written without an age limit, but its trials were in children and teenagers, and its dosing section is written for pediatric patients. An adult taking Focalin tablets is within the wording of the indication, but the label itself offers little adult-specific information.

How Focalin XR releases the medicine

The label says each Focalin XR capsule contains half its dexmethylphenidate as immediate-release beads and half as enteric-coated, delayed-release beads, producing a "bi-modal" profile with two peaks about 4 hours apart in healthy adults. The capsule can be swallowed whole or opened and the beads sprinkled on a spoonful of applesauce, swallowed right away without chewing. The label says not to chew, crush or divide the capsule or the beads. Release designs across products are compared in extended-release ADHD medications explained.

What the adult trial showed

The Focalin XR label describes a 5-week randomized, double-blind, placebo-controlled study in adults aged 18 to 60 with ADHD, with 101 adults treated for at least six months. The most common adverse reactions in adults (5% or more and at least twice the placebo rate) were dry mouth, indigestion (dyspepsia), headache, anxiety and sore throat (pharyngolaryngeal pain). During the double-blind phase, 10.7% of people on Focalin XR and 7.5% on placebo stopped because of side effects.

For the immediate-release tablet, the most common reactions listed in children and teenagers were abdominal pain, fever, nausea and loss of appetite. Weight loss in adult ADHD patients appears in its list of reactions reported with methylphenidate products. More on recognizing side effects is in ADHD medication side effects in adults.

Boxed warning

Both Focalin labels carry the stimulant class boxed warning on abuse, misuse and addiction. It warns of a high potential for misuse that can lead to a substance use disorder, and of overdose and death with misuse, particularly at higher doses or by unapproved routes. The FDA required this wording for all prescription stimulants in May 2023.

Other warnings

• Avoid use in people with known serious heart disease; monitor blood pressure and pulse (see heart health and blood pressure).
• Screen for risk of mania before starting; new psychotic or manic symptoms call for reassessment.
• Priapism (a prolonged, painful erection) needs immediate care.
• Circulation changes in fingers and toes, including Raynaud's phenomenon.
• Acute angle closure glaucoma and raised eye pressure.
• New or worsening tics and Tourette's syndrome.

Who should not take it

Contraindications are an allergy to methylphenidate or another ingredient, and use of a monoamine oxidase inhibitor (MAOI) now or within 14 days, because the combination can cause a hypertensive crisis.

Interactions

The Focalin XR interaction table lists MAOIs, blood pressure medicines (which may work less well), halogenated anesthetics on the day of surgery, and risperidone, where a dose change of either drug may raise the risk of movement side effects. See ADHD medication drug interactions.

Pregnancy and breastfeeding

Both labels point to the National Pregnancy Registry for ADHD Medications. Their lactation sections say limited published data show methylphenidate in human milk, with no reported effects on breastfed infants or milk production, and unknown long-term effects. They advise watching a breastfed infant for agitation, poor sleep, poor feeding and reduced weight gain. LactMed summarizes the research on methylphenidate, and ADHD in pregnancy and postpartum covers decisions around pregnancy.

Generics and cost

FDA's Drugs@FDA database lists many approved generic applications for dexmethylphenidate tablets and extended-release capsules. Generics are usually cheaper than brand, though prices and coverage vary by plan and pharmacy. When FDA's drug shortage database was checked in mid-October 2026, mixed amphetamine salts immediate-release, lisdexamfetamine and methylphenidate extended-release were listed as current shortages. Shortage status changes often, so check the database or ask your pharmacy about dexmethylphenidate before a prescription runs out.

New York and New Jersey rules

As a Schedule II drug, dexmethylphenidate cannot be refilled in either state. New York caps a prescription at a 30-day supply unless it is written for a condition the state allows up to three months for, including attention deficit disorder (New York's rules). New Jersey caps each prescription at 30 days, with multiple dated prescriptions allowed up to 90 days, and since July 8, 2026 adults located in New Jersey who start a Schedule II stimulant by telehealth need an in-person visit within 30 days (New Jersey's rules).

How it compares

A 2018 network meta-analysis in Lancet Psychiatry found methylphenidate reduced adult ADHD symptoms more than placebo at about 12 weeks; it did not separately rank dexmethylphenidate. For a direct comparison see Focalin vs Ritalin. A newer once-daily product that combines dexmethylphenidate with a prodrug is covered in Azstarys for adults.

Questions to ask your prescriber

• Is the immediate-release tablet or the XR capsule a better match for my day?
• If I am switching from regular methylphenidate, how will the change be handled?
• Can I open the XR capsule if I have trouble swallowing?
• Which side effects should prompt a call, and how will my blood pressure be checked?

Dr. Shershow evaluates adults for ADHD and manages medication when it is appropriate. See adult ADHD treatment.